Merck & Co Inc

NYSE: MRK
$126.88
-$0.06 (0.0%)
Closing price April 23, 2024
Merck & Co Inc is a global healthcare leader known for its innovative pharmaceuticals and animal health products. With a rich history dating back to 1891, Merck has made significant strides in oncology, immunology, neuroscience, and more, offering well-known brands like Keytruda and Januvia. Its pharmaceutical segment focuses on human health, while the Animal Health division provides veterinary pharmaceuticals and services. Merck collaborates with industry giants like AstraZeneca and Bayer, emphasizing its commitment to advancing healthcare across both human and animal sectors.
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
With the second quarter now underway, these seven top dividend-paying Goldman Sachs stock picks make sense for growth and income investors who are looking for stocks that are still offering...
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Boeing, Coinbase Global, Costco Wholesale, Envista, Merck, New Fortress Energy, NexTier Oilfield Solutions, Radius Global...
Thursday's top analyst upgrades and downgrades included Alcoa, American International Group, BioCryst Pharmaceuticals, Coinbase Global, GitLab, Home Depot, Merck, Nvidia, Palo Alto Networks,...
The best strategy for worried investors now may be to move from riskier assets to dividend-paying stocks that can hold their ground if we slip into a recession, such as these six defensive picks from...
With the economic storm clouds growing, what is the smart move for investors now? These seven safe-haven stocks can withstand a brutal market sell-off, come with big and reliable dividends and are...
These four companies, including one Dow Jones industrial, are set to report quarterly earnings early Thursday.
Thursday's top analyst upgrades and downgrades included Baidu, Bank of New York Mellon, Charles Schwab, Corning, Livent, Merck, Meta Platforms, Microsoft, Nucor, Okta, Pfizer, Rivian Automotive,...
Unless you are a hedge fund portfolio manager who has spent 2022 shorting tech stocks and cryptocurrencies, like most investors you are more than ready to flip the calendar, and with just over 5...
The futures are trading lower as we start the Thanksgiving holiday-shortened trading week. The stock market is closed on the big turkey day, and will also shutter  early at 1 pm EST on Black Friday....
Given the teetering market and a sputtering economy, the best ideas for nervous investors now are the safest. These eight Goldman Sachs Conviction List stock picks are dividend-paying blue chips with...
Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck, Procter & Gamble, Toast and more.
Here are seven defensive dividend leader stocks that look like outstanding ideas for worried investors now. With even moderate appreciation in the share prices of these top companies, investors...
Wednesday's additional top analyst upgrades and downgrades were on Block, Bristol-Myers Squibb, Clorox, CSX, Kimberly-Clark, Merck, Match, Target and more.